Affiliations 

  • 1 School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom
  • 2 School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom bimba@bris.ac.uk
Antimicrob Agents Chemother, 2020 06 23;64(7).
PMID: 32312773 DOI: 10.1128/AAC.02208-19

Abstract

Meropenem-vaborbactam resistance in Klebsiella pneumoniae isolates is associated with loss-of-function mutations in the OmpK35 and OmpK36 porins. We identify two previously unknown loss-of-function mutations that confer cefuroxime resistance in K. pneumoniae isolates. The proteins lost were NlpD and KvrA; the latter is a transcriptional repressor that controls capsule production. We demonstrate that KvrA loss reduces OmpK35 and OmpK36 porin production, which confers reduced susceptibility to meropenem-vaborbactam in a KPC-3-producing K. pneumoniae isolate.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.